Skip to main content

Table 3 Adherence outcomes over the six month intervention period by study condition

From: Randomized controlled trial of a theory-informed mHealth intervention to support ART adherence and viral suppression among women with HIV in Mombasa, Kenya: preliminary efficacy and participant-level feasibility and acceptability

 

All

% (n/N)

Intervention

% (n/N)

Control

% (n/N)

Relative Risk (RR)

95% CI for RR

p-value*

Perfect Adherence by VAS

      

Month 1

Month 2

Month 3

Month 4

Month 5

Month 6

82.6 (90/109)

88.0 (88/100)

89.8 (88/98)

86.0 (86/100)

83.5 (81/97)

83.5 (81/97)

93.0 (53/57)

88.2 (45/51)

90.2 (46/51)

88.0 (44/50)

89.8 (44/49)

87.2 (41/47)

71.2 (37/52)

87.8 (43/49)

89.4 (42/47)

84.0 (42/50)

77.1 (37/48)

80.0 (40/50)

1.31

1.01

1.01

1.05

1.16

1.09

1.08, 1.58

0.87, 1.16

0.88, 1.15

0.89, 1.23

0.97, 1.40

0.91, 1.30

0.01

0.91

0.90

0.59

0.09

0.32

  1. *Relative Risk from log binomial generalized linear model.